MacGregor Duncan G, Avshalumov Marat V, Rice Margaret E
Department of Neurosurgery, New York University School of Medicine, New York 10016, USA.
J Neurochem. 2003 Jun;85(6):1402-11. doi: 10.1046/j.1471-4159.2003.01772.x.
Decreased cerebral blood flow, hence decreased oxygen and glucose, leads to ischemic brain injury via complex pathophysiological events, including excitotoxicity, mitochondrial dysfunction, increased intracellular Ca2+, and reactive oxygen species (ROS) generation. Each of these could also contribute to cerebral edema, which is the primary cause of patient mortality after stroke. In vitro brain slices are widely used to study ischemia. Here we introduce a slice model to investigate ischemia-induced edema. Significant water gain was induced in coronal slices of rat brain by 5 min of oxygen and glucose deprivation (OGD) at 35 degrees C, with progressive edema formation after return to normoxic, normoglycemic medium. Edema increased with increasing injury severity, determined by OGD duration (5-30 min). Underlying factors were assessed using glutamate-receptor antagonists (AP5/CNQX), blockade of mitochondrial permeability transition [cyclosporin A (CsA) versus FK506], inhibition of Na+/Ca2+ exchange (KB-R7943), and ROS scavengers (ascorbate, Trolox, dimethylthiourea, Tempol). All agents except KB-R7943 and FK506 significantly attenuated edema when applied after OGD; KB-R7943 was effective when applied before OGD. Significantly, complete prevention of ischemia-induced edema was achieved with a cocktail of AP5/CNQX, CsA and Tempo applied after OGD, which demonstrates the involvement of multiple, additive mechanisms. The efficacy of this cocktail further shows the potential value of combination therapies for the treatment of cerebral ischemia.
脑血流量减少,进而导致氧气和葡萄糖供应减少,通过复杂的病理生理过程引发缺血性脑损伤,这些过程包括兴奋性毒性、线粒体功能障碍、细胞内钙离子浓度升高以及活性氧(ROS)生成。这些因素中的每一个都可能导致脑水肿,而脑水肿是中风后患者死亡的主要原因。体外脑片被广泛用于研究缺血。在此,我们介绍一种脑片模型来研究缺血诱导的水肿。在35摄氏度下对大鼠脑冠状切片进行5分钟的氧糖剥夺(OGD)可诱导显著的水分增加,恢复到常氧、常糖培养基后会逐渐形成水肿。水肿程度随着由OGD持续时间(5 - 30分钟)决定的损伤严重程度增加而加重。使用谷氨酸受体拮抗剂(AP5/CNQX)、线粒体通透性转换阻断剂[环孢素A(CsA)与FK506]、钠/钙交换抑制剂(KB - R7943)以及ROS清除剂(抗坏血酸、曲洛司坦、二甲基硫脲、Tempol)评估潜在因素。除KB - R7943和FK506外,所有药物在OGD后应用时均能显著减轻水肿;KB - R7943在OGD前应用时有效。值得注意的是,在OGD后应用AP5/CNQX、CsA和Tempol的组合可完全预防缺血诱导的水肿,这表明存在多种相加机制。这种组合疗法的有效性进一步显示了联合治疗在脑缺血治疗中的潜在价值。